Embracing Technology: FDA Releases Draft Guidance on Decentralized Clinical Trials
Hall Render
SEPTEMBER 14, 2023
The guidance describes DCT-specific considerations that may not be present in site-based clinical trials, and how sponsors can approach such issues. DCTs often present novel problems that sponsors conducting site-based clinical trials have not previously encountered.
Let's personalize your content